Similar Search Results

Generic entry in a regulated pharmaceutical market

Iizuka, Toshiaki - In: The Japanese economic review : the journal of the … 60 (2009) 1, pp. 63-81

Persistent link: https://www.econbiz.de/10003845844

The effect of inertia on brand-name versus generic drug choices

Ito, Yuki; Hara, Konan; Kobayashi, Yasuki - In: Journal of economic behavior & organization : JEBO 172 (2020), pp. 364-379

Persistent link: https://www.econbiz.de/10012288243

Ways to battle the $ 431 billion fake pharmaceutical industry

Gurney, Brian; Amundson, Gary; Boumediene, Salem L. - In: Review of business & finance studies : RBFS 8 (2017) 1, pp. 33-40

Persistent link: https://www.econbiz.de/10011698033

The diffusion of generics after patent expiry in Germany

Blankart, Katharina; Stargardt, Tom - In: The European journal of health economics : HEPAC ; … 17 (2016) 8, pp. 1027-1040

Persistent link: https://www.econbiz.de/10011660160

The generic drug user fee amendments : an economic perspective

Berndt, Ernst R.; Conti, Rena M.; Murphy, Stephen J. - 2017

Persistent link: https://www.econbiz.de/10011713225

Generic Entry in a Regulated Pharmaceutical Market

Iizuka, Toshiaki - 2014

prescription pattern driven by the price regulation and healthcare system. Fewer generics enter if the drug is more frequently …

Persistent link: https://www.econbiz.de/10014210344

The effects of price regulation on pharmaceutical expenditure and availability

Kortelainen, Mika; Markkanen, Jaakko; Siilkanen, Markku; … - 2023

Persistent link: https://www.econbiz.de/10014635853

Regulation of brands in the Indian pharmaceutical industry in the 1960s : examination of the Tariff Commission Report : 1968

Kanchan, Manu - In: IIMB Management Review 36 (2024) 1, pp. 83-92

The literature on the Indian pharmaceutical industry has examined the importance of product patents and the attempts policy has made to regulate them. However, it has not done the same for the question of brands. Our study addresses this gap. The Tariff Commission Report of 1968, a turning point...

Persistent link: https://www.econbiz.de/10014636929

Reforming the Swedish pharmaceuticals market : consequences for costs per defined daily dose

Bergman, Mats A.; Granlund, David; Rudholm, Niklas - In: International journal of health economics and management 16 (2016) 3, pp. 201-214

Persistent link: https://www.econbiz.de/10011811445

Magic on the internet : experimental tests of auction theory

Reiley, David H. - 1996

Persistent link: https://www.econbiz.de/10000969449